Stocks and InvestingStocks and Investing
Fri, July 5, 2024
Wed, July 3, 2024
Tue, July 2, 2024
Mon, July 1, 2024

Raghuram Selvaraju Reiterated (URGN) at Strong Buy and Held Target at $60 on, Jul 1st, 2024


Published on 2024-10-28 12:12:24 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Reiterated "UroGen Pharma Ltd." (URGN) at Strong Buy and Held Target at $60 on, Jul 1st, 2024.

Raghuram has made no other calls on URGN in the last 4 months.



There are 2 other peers that have a rating on URGN. Out of the 2 peers that are also analyzing URGN, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Raghuram


  • Leland Gershell of "Oppenheimer" Maintained at Buy with Increased Target to $40 on, Friday, June 14th, 2024
  • Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $54 on, Friday, June 14th, 2024